225 related articles for article (PubMed ID: 20697956)
1. Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo.
Finlay TM; Abdulkhalek S; Gilmour A; Guzzo C; Jayanth P; Amith SR; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Aug; 27(6):583-600. PubMed ID: 20697956
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245
[TBL] [Abstract][Full Text] [Related]
3. Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase.
Amith SR; Jayanth P; Franchuk S; Siddiqui S; Seyrantepe V; Gee K; Basta S; Beyaert R; Pshezhetsky AV; Szewczuk MR
Glycoconj J; 2009 Dec; 26(9):1197-212. PubMed ID: 19430901
[TBL] [Abstract][Full Text] [Related]
4. G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signaling.
Abdulkhalek S; Guo M; Amith SR; Jayanth P; Szewczuk MR
Cell Signal; 2012 Nov; 24(11):2035-42. PubMed ID: 22759791
[TBL] [Abstract][Full Text] [Related]
5. Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling.
Amith SR; Jayanth P; Franchuk S; Finlay T; Seyrantepe V; Beyaert R; Pshezhetsky AV; Szewczuk MR
Cell Signal; 2010 Feb; 22(2):314-24. PubMed ID: 19796680
[TBL] [Abstract][Full Text] [Related]
6. Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses.
Abdulkhalek S; Szewczuk MR
Cell Signal; 2013 Nov; 25(11):2093-105. PubMed ID: 23827939
[TBL] [Abstract][Full Text] [Related]
7. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling.
Abdulkhalek S; Amith SR; Franchuk SL; Jayanth P; Guo M; Finlay T; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
J Biol Chem; 2011 Oct; 286(42):36532-49. PubMed ID: 21873432
[TBL] [Abstract][Full Text] [Related]
8. A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes.
Alghamdi F; Guo M; Abdulkhalek S; Crawford N; Amith SR; Szewczuk MR
Cell Signal; 2014 Jun; 26(6):1355-68. PubMed ID: 24583283
[TBL] [Abstract][Full Text] [Related]
9. Detection of Neu1 sialidase activity in regulating Toll-like receptor activation.
Amith SR; Jayanth P; Finlay T; Franchuk S; Gilmour A; Abdulkhalek S; Szewczuk MR
J Vis Exp; 2010 Sep; (43):. PubMed ID: 20864924
[TBL] [Abstract][Full Text] [Related]
10. Biased G protein-coupled receptor agonism mediates Neu1 sialidase and matrix metalloproteinase-9 crosstalk to induce transactivation of insulin receptor signaling.
Haxho F; Haq S; Szewczuk MR
Cell Signal; 2018 Mar; 43():71-84. PubMed ID: 29277445
[TBL] [Abstract][Full Text] [Related]
11. Interplay Between Sialic Acids, Siglec-E, and Neu1 Regulates MyD88- and TRIF-Dependent Pathways for TLR4-Activation During
Karmakar J; Mandal C
Front Immunol; 2021; 12():626110. PubMed ID: 33763070
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.
Ben Haij N; Planès R; Leghmari K; Serrero M; Delobel P; Izopet J; BenMohamed L; Bahraoui E
PLoS One; 2015; 10(6):e0129425. PubMed ID: 26090662
[TBL] [Abstract][Full Text] [Related]
13. Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.
Feng C; Stamatos NM; Dragan AI; Medvedev A; Whitford M; Zhang L; Song C; Rallabhandi P; Cole L; Nhu QM; Vogel SN; Geddes CD; Cross AS
PLoS One; 2012; 7(4):e32359. PubMed ID: 22496731
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis.
Chen T; Huang W; Qian J; Luo W; Shan P; Cai Y; Lin K; Wu G; Liang G
EBioMedicine; 2020 Mar; 53():102706. PubMed ID: 32151799
[TBL] [Abstract][Full Text] [Related]
15. Heme induces inflammatory injury by directly binding to the complex of myeloid differentiation protein 2 and toll-like receptor 4.
Lin J; Lin K; Huang L; Jiang Y; Ding X; Luo W; Samorodov AV; Pavlov VN; Liang G; Qian J; Wang Y
Toxicol Lett; 2022 Nov; 370():15-23. PubMed ID: 36115635
[TBL] [Abstract][Full Text] [Related]
16. A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway.
Tundup S; Srivastava L; Norberg T; Watford W; Harn D
PLoS One; 2015; 10(9):e0137495. PubMed ID: 26340260
[TBL] [Abstract][Full Text] [Related]
17. Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
Yang Y; Sheng Y; Wang J; Zhou X; Guan Q; Shen H; Li W; Ruan S
J Cell Mol Med; 2021 Aug; 25(15):7257-7269. PubMed ID: 34184406
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation.
Fan H; Peck OM; Tempel GE; Halushka PV; Cook JA
Shock; 2004 Jul; 22(1):57-62. PubMed ID: 15201703
[TBL] [Abstract][Full Text] [Related]
19. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol.
Byrd-Leifer CA; Block EF; Takeda K; Akira S; Ding A
Eur J Immunol; 2001 Aug; 31(8):2448-57. PubMed ID: 11500829
[TBL] [Abstract][Full Text] [Related]
20. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.
Kim S; Kim SY; Pribis JP; Lotze M; Mollen KP; Shapiro R; Loughran P; Scott MJ; Billiar TR
Mol Med; 2013 May; 19(1):88-98. PubMed ID: 23508573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]